Ifosfamide and Cisplatin as Neoadjuvant Chemotherapy for Advanced Cervical Carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ifosfamide and Cisplatin as Neoadjuvant Chemotherapy for Advanced Cervical Carcinoma

Published:1996-04 Issue:2 Volume:19 Page:132-135
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Leone B.,Vallejo C.,Perez J.,Cuevas M. A.,Machiavelli M.,Lacava J.,Focaccia G.,Ferreyra R.,Suttora G.,Romero A.,Castaldi J.,Arroyo A.,Rabinovich M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference19 articles.

1. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: A 20-year experience

2. New approaches to high-risk cervical cancer: Advanced cervical cancer

3. Phase II Studies of Bleomycin, Ifosfamide and Cis-Platinum in Advanced and Recurrent Cervical Carcinoma

4. Combination Bleomycin, Ifosfamide, and Cisplatin Chemotherapy in Cervical Cancer

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of weekly paclitaxel-carboplatin plus standard bevacizumab as neoadjuvant treatment in stage IB–IIB cervical cancer;International Journal of Gynecologic Cancer;2021-04-15

2. Advances in paclitaxel combinations for treating cervical cancer;Expert Opinion on Pharmacotherapy;2020-02-08

3. Neoadjuvant Weekly Paclitaxel-Carboplatin Is Effective in Stage I–II Cervical Cancer;International Journal of Gynecologic Cancer;2017-07

4. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma;Journal of Gynecologic Oncology;2015

5. Adjuvant chemotherapy after primary treatments for cervical cancer: a critical point of view and review of the literature;Expert Review of Anticancer Therapy;2014-02-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3